Literature DB >> 2428128

The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens.

N Odum, R Hartzman, B K Jakobsen, N Morling, P Platz, F M Robbins, L P Ryder, A Svejgaard.   

Abstract

Lymphocytes from highly selected donors were primed for 10 days and subsequently bulk-expanded in IL 2 (TCGF) containing cultures. Two well-discriminatory PLT (CDP = Copenhagen DP) reagents against each of the DPw1-w6 specificities and one against each of the two "new" specificities, CDP4s and CDPHEI, were selected for further studies. Three combinations made in two recombinant families and four of ten HLA-A, B, and DR compatible combinations discriminated well in contrast to seven of 46 DR compatible, but HLA-A or B incompatible combinations. All reagents gave highly reproducible results, and high correlations (r-values between 0.73-1.00) for DP assignments were obtained with CDP and GNN reagents. No triplets were found for the DPw1-w6 and CDP HEI specificities. The "new" specificity CDP HEI defined in an HLA-DR/GLO recombinant family gave a coefficient of correlation with GNN 8 of 0.91. Another "new" specificity, CDP4s constitutes a subgroup ("split") of DPw4. The gene frequencies of DPw1-w6 estimated in 102 unrelated randomly selected Danes agreed with those reported for other Caucasoid populations. The gene frequencies CDP HEI and CDP4s were 0.03 and 0.08, respectively. The associations between DR3-DPw1, DR2-DPw4, and DRw6-DPw2 were confirmed. It is concluded that DP-typing with bulk-expanded reagents is a reliable and so far the only technique which can reveal the polymorphism of the DP gene products.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428128     DOI: 10.1111/j.1399-0039.1986.tb00468.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

1.  Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.

Authors:  Anders Woetmann; Paola Lovato; Karsten W Eriksen; Thorbjørn Krejsgaard; Tord Labuda; Qian Zhang; Anne-Merethe Mathiesen; Carsten Geisler; Arne Svejgaard; Mariusz A Wasik; Niels Ødum
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

2.  Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.

Authors:  N Odum; N Morling; P Platz; B Hofmann; L P Ryder; C Heilmann; F K Pedersen; L P Nielsen; J Friis; A Svejgaard
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

3.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Restriction fragment length polymorphism of DP genes defines three new DP alleles.

Authors:  Y Mitsuishi; A Urlacher; M M Tongio; S Mayer
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes.

Authors:  J J Hyldig-Nielsen; N Morling; N Odum; L P Ryder; P Platz; B Jakobsen; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis.

Authors:  L Fugger; L P Ryder; N Morling; N Odum; J Friis; F K Pedersen; C Heilmann; M Sandberg-Wollheim; A Svejgaard
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Southern blot analysis of HLA-DP gene polymorphisms in Caucasoid rheumatoid arthritis (RA) patients and controls.

Authors:  H A Stephens; R W Vaughan; L I Sakkas; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  DNA polymorphism of HLA class II genes in primary biliary cirrhosis.

Authors:  N Morling; K Dalhoff; L Fugger; J Georgsen; B Jakobsen; L Ranek; N Odum; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Typing for HLA-DPB1*03 and HLA-DPB1*06 using allele-specific DNA in vitro amplification and allele-specific oligonucleotide probes. Detection of "new" DPB1*06 variants.

Authors:  L Fugger; N Morling; L P Ryder; N Odum; J Georgsen; A Svejgaard
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.